• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Syndecan-4是一种在血管平滑肌细胞中由碱性成纤维细胞生长因子和动脉损伤诱导产生的初级反应基因。

Syndecan-4 is a primary-response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells.

作者信息

Cizmeci-Smith G, Langan E, Youkey J, Showalter L J, Carey D J

机构信息

Sigfried and Janet Weis Center for Research, Geisinger Clinic, Danville, Pa 17822-2613, USA.

出版信息

Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):172-80. doi: 10.1161/01.atv.17.1.172.

DOI:10.1161/01.atv.17.1.172
PMID:9012653
Abstract

Syndecans are a family of transmembrane proteoglycans that have been implicated in cell-extracellular matrix adhesion and growth factor binding. We reported previously that syndecan-1 expression by cultured rate vascular smooth muscle cells (VSMCs) is induced by serum- or platelet-derived growth factor (PDGF). We now report that syndecan-4 mRNA is rapidly induced in cultured VSMCs in response to basic fibroblast growth factor (bFGF) or serum stimulation. In the presence of cycloheximide, induction of syndecan-4 mRNA was enhanced. These characteristics identified syndecan-4 as a primary-response gene product in VSMCs. In contrast, syndecan-1 mRNA expression in response to serum was completely blocked in the presence of cycloheximide. We also examined the expression of syndecan mRNAs in VSMCs in response to balloon catheter injury in vivo. A reverse transcriptase-polymerase chain reaction technique was developed that enabled us to amplify all four syndecan mRNAs in a single reaction tube and determine relative changes in their expression. All four syndecan mRNAs were detected in uninjured rat carotid arteries. In endothelium-denuded arteries, the medial layer (presumably VSMCs) accounted for 70% to 90% of the syndecan mRNAs in the vessel wall. The levels of syndecan-2 and syndecan-3 mRNAs were not altered significantly after balloon injury. In contrast, syndecan-4 mRNA was increased at early times after injury but then decreased to control level by 7 days. Syndecan-1 mRNA levels showed a slower but prolonged increase that reached a maximum at 7 days after injury. Immunostaining with anti-syndecan-4 antibodies demonstrated a rapid increase in syndecan-4 proteoglycan expression in the injured carotid artery.

摘要

Syndecans是一族跨膜蛋白聚糖,与细胞-细胞外基质黏附及生长因子结合有关。我们先前报道,培养的大鼠血管平滑肌细胞(VSMC)中syndecan-1的表达受血清或血小板衍生生长因子(PDGF)诱导。我们现在报道,培养的VSMC中syndecan-4 mRNA在碱性成纤维细胞生长因子(bFGF)或血清刺激后迅速被诱导。在存在放线菌酮的情况下,syndecan-4 mRNA的诱导增强。这些特征确定syndecan-4为VSMC中的一种初级反应基因产物。相反,在存在放线菌酮的情况下,血清诱导的syndecan-1 mRNA表达被完全阻断。我们还检测了体内VSMC中syndecan mRNA对球囊导管损伤的反应。开发了一种逆转录-聚合酶链反应技术,使我们能够在单个反应管中扩增所有四种syndecan mRNA,并确定它们表达的相对变化。在未损伤的大鼠颈动脉中检测到所有四种syndecan mRNA。在内皮剥脱的动脉中,中层(可能是VSMC)占血管壁中syndecan mRNA的70%至90%。球囊损伤后syndecan-2和syndecan-3 mRNA的水平没有明显改变。相反,syndecan-4 mRNA在损伤后早期增加,但在7天时降至对照水平。syndecan-1 mRNA水平显示出较慢但持续时间较长的增加,在损伤后7天达到最大值。用抗syndecan-4抗体进行免疫染色显示,损伤的颈动脉中syndecan-4蛋白聚糖表达迅速增加。

相似文献

1
Syndecan-4 is a primary-response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells.Syndecan-4是一种在血管平滑肌细胞中由碱性成纤维细胞生长因子和动脉损伤诱导产生的初级反应基因。
Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):172-80. doi: 10.1161/01.atv.17.1.172.
2
Differential expression of transmembrane proteoglycans in vascular smooth muscle cells.跨膜蛋白聚糖在血管平滑肌细胞中的差异表达。
J Biol Chem. 1993 Sep 5;268(25):18740-7.
3
Expression of syndecan-2, -4, and fibroblast growth factor receptor type 1 in human periodontal ligament fibroblasts and down-regulation of these membrane proteins during maturation in culture.Syndecan-2、-4和成纤维细胞生长因子受体1在人牙周膜成纤维细胞中的表达以及在培养成熟过程中这些膜蛋白的下调。
J Dent Res. 1999 Dec;78(12):1791-9. doi: 10.1177/00220345990780120501.
4
Thrombin stimulates syndecan-1 promotor activity and expression of a form of syndecan-1 that binds antithrombin III in vascular smooth muscle cells.凝血酶可刺激Syndecan-1启动子活性,并在血管平滑肌细胞中表达一种能结合抗凝血酶III的Syndecan-1形式。
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2609-16. doi: 10.1161/01.atv.17.11.2609.
5
Growth factors and cytokines modulate gene expression of cell-surface proteoglycans in human periodontal ligament cells.生长因子和细胞因子调节人牙周膜细胞中细胞表面蛋白聚糖的基因表达。
J Cell Physiol. 2001 Mar;186(3):448-56. doi: 10.1002/1097-4652(2001)9999:9999<000::AID-JCP1047>3.0.CO;2-V.
6
Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty.血小板衍生生长因子刺激后血管平滑肌细胞和球囊血管成形术后颈动脉中骨桥蛋白的表达。
Arterioscler Thromb Vasc Biol. 1996 Nov;16(11):1365-72. doi: 10.1161/01.atv.16.11.1365.
7
Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.细胞表面硫酸乙酰肝素蛋白聚糖控制肾间质成纤维细胞对成纤维细胞生长因子-2的反应。
Kidney Int. 2001 Jun;59(6):2084-94. doi: 10.1046/j.1523-1755.2001.00723.x.
8
Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.抑制蛋白酪氨酸激酶可减弱动脉损伤后转化生长因子-β亚型及其受体表达的增加。
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2461-70. doi: 10.1161/01.atv.17.11.2461.
9
Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.用肝素酶处理去除硫酸乙酰肝素可抑制损伤大鼠颈动脉中依赖碱性成纤维细胞生长因子-2的平滑肌细胞增殖。
Atherosclerosis. 2004 Jul;175(1):51-7. doi: 10.1016/j.atherosclerosis.2004.01.045.
10
Cell surface heparan sulfate proteoglycans: target and partners of the basic fibroblast growth factor in rat Sertoli cells.
Eur J Biochem. 2002 Jan;269(2):502-11. doi: 10.1046/j.0014-2956.2001.02672.x.

引用本文的文献

1
Is There Enough Evidence to Support the Role of Glycosaminoglycans and Proteoglycans in Thoracic Aortic Aneurysm and Dissection?-A Systematic Review.是否有足够的证据支持糖胺聚糖和蛋白聚糖在胸主动脉瘤和夹层中的作用?——系统评价。
Int J Mol Sci. 2022 Aug 16;23(16):9200. doi: 10.3390/ijms23169200.
2
Syndecan-1 downregulates syndecan-4 expression by suppressing the ERK1/2 and p38 MAPK signaling pathways in cultured vascular endothelial cells.Syndecan-1通过抑制培养的血管内皮细胞中的ERK1/2和p38 MAPK信号通路来下调Syndecan-4的表达。
Biochem Biophys Rep. 2021 Apr 24;26:101001. doi: 10.1016/j.bbrep.2021.101001. eCollection 2021 Jul.
3
Serum and tissue syndecan-1 levels in renal cell carcinoma.
肾细胞癌中血清和组织syndecan-1水平
Transl Androl Urol. 2020 Jun;9(3):1167-1176. doi: 10.21037/tau-19-787.
4
Extracellular histones are the ligands for the uptake of exosomes and hydroxyapatite-nanoparticles by tumor cells via syndecan-4.细胞外组蛋白是肿瘤细胞通过 syndecan-4 摄取外泌体和羟磷灰石纳米颗粒的配体。
FEBS Lett. 2018 Oct;592(19):3274-3285. doi: 10.1002/1873-3468.13236. Epub 2018 Sep 20.
5
Lack of association between serum syndecan-4, myocardial fibrosis and ventricular dysfunction in subjects with chronic Chagas disease.慢性恰加斯病患者血清syndecan-4、心肌纤维化与心室功能障碍之间无关联。
PLoS One. 2017 Dec 12;12(12):e0189408. doi: 10.1371/journal.pone.0189408. eCollection 2017.
6
Induction of Syndecan-4 by Organic-Inorganic Hybrid Molecules with a 1,10-Phenanthroline Structure in Cultured Vascular Endothelial Cells.具有1,10-菲咯啉结构的有机-无机杂化分子在培养的血管内皮细胞中诱导Syndecan-4的表达
Int J Mol Sci. 2017 Feb 8;18(2):352. doi: 10.3390/ijms18020352.
7
Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine.Syndecan-1在实体癌和血液系统癌症中的分子及临床特征用于预后评估和精准医学
Oncotarget. 2015 Oct 6;6(30):28693-715. doi: 10.18632/oncotarget.4981.
8
Trans-regulation of Syndecan Functions by Hetero-oligomerization.通过异源寡聚化对Syndecan功能进行反式调节。
J Biol Chem. 2015 Jul 3;290(27):16943-53. doi: 10.1074/jbc.M114.611798. Epub 2015 May 15.
9
The Role of MicroRNAs in Vascular Diseases; Smooth Muscle Cell Differentiation and De-Differentiation.微小RNA在血管疾病中的作用;平滑肌细胞的分化与去分化
Korean Circ J. 2014 Jul;44(4):218-9. doi: 10.4070/kcj.2014.44.4.218.
10
Syndecans in cartilage breakdown and synovial inflammation.软骨降解和滑膜炎症中的连接蛋白。
Nat Rev Rheumatol. 2013 Jan;9(1):43-55. doi: 10.1038/nrrheum.2012.178. Epub 2012 Oct 23.